Investigating the mechanisms of Modified Xiaoyaosan (tiaogan-liqi prescription) in suppressing the progression of atherosclerosis, by means of integrative pharmacology and experimental validation

Atherosclerosis (AS)-related diseases remain among the leading causes of death worldwide. Modified Xiaoyaosan (also called Tiaogan-Liqi prescription, TGLQ), a traditional Chinese medical formulation, has been widely applied in the treatment of AS-related diseases. The aim of this study was to invest...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Mingtai, Luo, Yong, Men, Ling, Lin, Bo, Lin, Haidan, Li, Ying, Zhong, Guofu, Zhong, Xiaoling, Fu, Wenjun, Zhou, Hua, Tong, Guangdong, Liu, Qiang, Luan, Jienan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8109114/
https://www.ncbi.nlm.nih.gov/pubmed/33839698
http://dx.doi.org/10.18632/aging.202832

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8109114/
https://www.ncbi.nlm.nih.gov/pubmed/33839698
http://dx.doi.org/10.18632/aging.202832

Ejemplares similares